BIIB Financial Facts
Income from operations: 1.43BTotal revenues: 2.96B
See Full Income Statement
Intangible assets, net: 3.87B
Total Biogen Idec Inc. shareholders' equity: 12.12B
See Full Balance Sheet
Biogen Idec Inc. (BIIB) Earnings
|
Expand Research on BIIB
| Next EPS Date | 7/23/24 *Est. | EPS Growth Rate | +7.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +3.8% | Revenue Growth Rate | -6.9% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/15  |
 |
Q115 | $3.82 | $3.91 | -$0.09 | $2.56B | $2.66B |  |
 | | Details |
| 7/24/15 |
|
Q215 | $4.22 | $4.10 | +$0.12 | $2.59B | $2.71B | |
| | Details |
| 7/24/18 | |
Q218 | $5.80 | $5.24 | +$0.56 | $3.36B | $3.26B | = | | | Details |
| 1/29/15 |
|
Q414 | $4.09 | $3.78 | +$0.31 | $2.6B | $2.64B | |
| | Details |
| 1/25/18 | |
Q417 | $5.26 | $5.45 | -$0.19 | $3.31B | $3.08B | = | | | Details |
| 1/29/19 | |
Q418 | $6.99 | $6.74 | +$0.25 | $3.53B | $3.39B | |
| | Details |
| 4/22/20 | |
Q120 | $9.14 | $7.74 | +$1.40 | $3.53B | $3.41B | = | | | Details |
| 10/24/17 | |
Q317 | $6.31 | $5.70 | +$0.61 | $3.1B | $3.03B | = | | | Details |
